| BIO 301
Human Physiology
|
Body Defenses
Immunity
Major targets of body defense system:
Bacteria
Anti-bacterial defenses
The innate immune response functions as the first line of defence against infection. It consists of soluble factors, such as complement proteins, and diverse cellular components including granulocytes (basophils, eosinophils and neutrophils), mast cells, macrophages, dendritic cells and natural killer cells. The adaptive immune response is slower to develop, but manifests as increased antigenic specificity and memory. It consists of antibodies, B cells, and CD4+ and CD8+ T lymphocytes. Natural killer T cells and gamma-delta T cells are cytotoxic lymphocytes that straddle the interface of innate and adaptive immunity (Dranoff 2004). Dendritic cells are leucocytes that get their name from their surface projections that resemble the dendrites of neurons. They are found in most tissues of the body and are particularly abundant in those that are interfaces between the external and internal environments, e.g., skin and the lining of the gastrointestinal tract. Dencritic cells present antigen/self-antigen complexes that activate T-cells. Gamma-delta cells are primarily found in the intestine, the lining of the vagina, and the skin. They encounter antigens at those locations and, therefore, serve as a first line of defense.
Nonspecific Immune Responses
2 - Interferon - group of proteins that defend against viral infection
3 - Natural killer cells - lymphocyte-like cells that rather nonspecifically lyse & destroy virus-infected cells & cancer cells
4 - The complement system - inactive plasma proteins that, when activated, destroy foreign cells
Inflammation
(Check this animation)
Bacterial invasion or tissue damage
Release of histamine by mast cells (plus chemotaxins by damaged cells)
Arterial vasodilation & Increased capillary permeability
Increased blood flow to tissue & accumulation of fluid
Increased numbers of phagocytes & more clotting factors into surrounding tissues
Defense against foreign invader plus 'walling off' of inflamed area

http://www.biologymad.com/Immunology/inflammation.jpg
Interferon (check this animation - Antiviral activity of interferon):
Cell releases interferon
Interferon binds with receptors on uninvaded cells
Uninvaded cells produce enzymes capable of breaking down viral mRNA
Virus enters previously-uninvaded cell (now with interferon)
Virus-blocking enzymes are activated
Virus unable to multiply in newly invaded cells
Source: http://www.cat.cc.md.us/courses/bio141/lecguide/unit3/if.html

Complement system
2 - chemotaxins
3 - opsonins (bind with microbes & thereby enhance their phagocytosis)
5 - activate kinins - reinforces vascular changes induced by histamine & act as powerful chemotaxins
Source: National Cancer Institute |
Complement
The complement system consists of a series of proteins that work to "complement" the work of antibodies in destroying bacteria. Complement proteins circulate in the blood in an inactive form. The so-called "complement cascade" is set off when the first complement molecule, C1, encounters antibody bound to antigen in an antigen-antibody complex. Each of the complement proteins performs its specialized job in turn, acting on the molecule next in line. The end product is a cylinder that punctures the cell membrane and, by allowing fluids and molecules to flow in and out, dooms the target cell. |
Specific Immune Responses
Lymphocytes originate as stem cells in the bone
marrow. Some migrate to the Thymus & develop into T-cells;
others remain in the Bone marrow & develop into
B-cells. Both B- & T-cells then migrate to lymphoid tissue.

Organs and tissues of the immune system
(www.niaid.nih.gov)
B lymphocytes (or B cells) are most effective against bacteria
& their toxins plus a few viruses, while T lymphocytes (or T cells)
recognize
& destroy body cells gone awry, including virus-infected cells &
cancer cells.

Clonal selection and expansion of the vertebrate immune response (Figure from Bergstrom and Antia 2006)
The adaptive immune response of vertebrates works by clonal selection. Independent of exposure to an antigen or pathogen, the immune system generates a repertoire of immune cell lineages or clones (labeled 1–8 in the above Figure), each encoding a receptor with a predetermined shape and specificity. The human immune system creates in excess of 10,000,000 different clones. As a first approximation, those that react with self-antigens (numbers 3, 5, and 8 in Figure I) are deleted shortly after they mature. When the individual is infected with a pathogen, those clones that are specific for the pathogen (number 2 in the above Figure) will proliferate, producing a pathogen-specific immune cell population that is large enough to control that pathogen. This process is known as clonal expansion. After the pathogen is cleared, some of the pathogen-specific immune cells survive and confer immune memory (Bergstrom and Antia 2006).
How
do B & T cells recognize unwanted cells & other material?
B-cells:
Antibody-mediated immunity
Source: National Cancer Institute |
Activation
of B Cells to Make Antibody
The B cell uses its receptor to bind a matching antigen,
which it proceeds to engulf and process. Then it combines a fragment of
antigen with its special marker, the class II protein. This combination
of antigen and marker is recognized and bound by a T cell carrying a matching
receptor. The binding activates the T cell, which then releases lymphokines—interleukins—that
transform the B cell into an antibody- secreting plasma cell.
|
Humoral immunity
Antibodies

Source: NIAID


Source: Check (2007).
Source: National Cancer Institute |
IgA and IgM
IgA -- a doublet -- concentrates in body fluids such as tears, saliva, and the secretions of the respiratory and gastrointestinal tracts. It is, thus, in a position to guard the entrances to the body. IgM usually combines in star-shaped clusters. It tends to remain in the bloodstream, where it is very effective in killing bacteria. |

2 - agglutination (see example to the right)
3 - Enhancing activities of other defense systems:
Source: http://www.cat.cc.md.us/courses/bio141/lecguide/unit3/exo.html

The different biological effects of antibodies (Casadevall et al. 2004).
Plasma cells vs. Memory cells
Plasma cells:
Memory cells:
Primary response vs. Secondary response:

Active immunity vs. Passive immunity
Infants are born with relatively weak immune responses. They have, however, a natural "passive" immunity; they are protected during the first months of life by means of antibodies they receive from their mothers. The antibody IgG, which travels across the placenta, makes them immune to the same microbes to which their mothers are immune. Children who are nursed also receive IgA from breast milk; it protects the digestive tract. Passive immunity can also be conveyed by antibody-containing serum obtained from individuals who are immune to a specific infectious agent. Immune serum globulin or "gamma globulin" is sometimes given to protect travelers to countries where hepatitis is widespread. Passive immunity typically lasts only a few weeks.
"Active" immunity (mounting an immune response) can be triggered by both infection and vaccination. Vaccines contain microorganisms that have been altered so they will produce an immune response but will not be able to induce full-blown disease. Some vaccines are made from microbes that have been killed. Others use microbes that have been changed slightly so they can no longer produce infection. They may, for instance, be unable to multiply. Some vaccines are made from a live virus that has been weakened, or attenuated, by growing it for many cycles in animals or cell cultures.
T Lymphocytes: Cell-mediated Immunity (Also see - Immunology: Proliferation of the T cell)
Cytotoxic T cells:
Source:
National Cancer Institute
Helper T cells
Source:
National Cancer Institute
Suppressor T cells:
2 - normal self-antigens modified by drugs, environmental chemicals, viruses, or mutations
3 - exposure to antigen very similar to self-antigen ("molecular mimicry")

Major autoimmune diseases (Source: www.cdc.gov)
Red Blood Cells:
ABO system:
| Blood type | Antigen present |
|
|
|
|
|
|
|
|
|
|
|
|

Source: ghr.nlm.nih.gov
Antibodies:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
If you mix anti-A antibodies with blood cells that have the A antigen
OR mix anti-B antibodies with blood cells that have the B antigen, the
results will be AGGLUTINATION (or clumping of red blood cells). This
reaction can be used to type blood. You simply take two drops of 'unknown'
blood and place a drop of anti-A antibody solution on one blood drop &
a drop of anti-B antibody solution on the other blood drop. Then,
look closely to see if any clumping occurs. If clumping occurs in the
drop of blood where you added the anti-A antibodies, then you know that
the A antigen is present (and, of course, if there is no clumping, then
the A antigen is not present). If clumping occurs in the drop of blood
where you added the anti-B antibodies, then you know that the B antigen
is present (and, of course, if there is no clumping, then the B antigen
is not present). Using this information, you can determine the blood type:
|
anti-A antibody was added |
anti-B antibody was added |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Type O blood is the most common blood type, followed by type A, type B, and, the least common blood type, AB.
O+ 37%, O- 6%, A+ 34%, A- 6%,
B+ 10%, B- 2%, AB+ 4%, AB-
1%
In the above chart, the blood types are listed with either a + or -. The + or - refers to the presence or absence of the Rh factor.
Type O:
Rh system:
Erythroblastosis fetalis (also called Rh
disease):
Literature cited:
Bergstrom, C. T. and R. Antia. 2006. How do adaptive immune systems control pathogens while avoiding autoimmunity? Trends in Ecology and Evolution 21:22-28.
Related links:
Cell Mediated and Humoral Immunity
Understanding the Immune System
Lecture Notes 1 - Cell Structure & Metabolism
Lecture Notes 2 - Neurons & the Nervous System I
Lecture Notes 2b - Neurons & the Nervous System II
Lecture Notes 4 - Blood and Body Defenses I
Lecture Notes 5 - Cardiovascular System
Lecture Notes 6 - Respiratory System
Literature cited:
Casadevall, A., E. Dadachova, and L.-a. Pirofski. 2004. Passive antibody therapy for infectious diseases. Nature Reviews Microbiology 2: 695-703.
Check, E. 2007. Immunology: pimp my antibody. Nature 446: 964-966.
Dranoff, G. 2004. Cytokines in cancer pathogenesis and cancer therapy. Nature Reviews Cancer 4: 11-22.
Gray, D. 2002. A role for antigen in the maintenance of immunological memory. Nature Reviews Immunology 2: 60-65.
Ricklin, D. and J. D. Lambris. 2007. Complement-targeted therapeutics. Nature Biotechnology 25: 1265-1275.